Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
-39.79%
-60.41%
-169.54%
236.31%
74.92%
45.72%
33.08%
ROA
-32.06%
-35.59%
-55.51%
-147.03%
389.84%
88.15%
50.38%
Gross Margin
100%
100%
100%
100%
100%
100%
100%
Sector average
-
17.71%
17.71%
17.71%
17.71%
17.71%
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Cinclus Pharma Holding AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
62.35%
Total Assets
SEK 546,556.00K
SEK 424,540.00K
SEK 245,589.98K
SEK 50,171.10K
-
-
-
Sector average
-
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
SEK 1,806,991.80K
Net Income
-SEK 183,972.00K
-SEK 172,805.47K
-SEK 185,990.15K
-SEK 217,434.90K
-SEK 240,453.86K
-SEK 261,491.91K
-SEK 278,474.07K
Sector average
-
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
-SEK 13,704.11K
Valuation
-
SEK 896,317.82K
SEK 964,704.90K
SEK 1,127,804.42K
SEK 1,247,200.56K
SEK 1,356,322.00K
SEK 1,444,406.05K
Sector average
-
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
SEK 3,179,755.44K
Stock Price
-
SEK 19.26
SEK 20.73
SEK 24.23
SEK 26.80
SEK 29.14
SEK 31.04
Sector average
-
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
SEK 36.70
Cinclus Pharma Holding AB (publ) (CINPHA.ST) Financial Forecast | Equlion
